These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38213725)

  • 21. Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
    Ren H; Chen Z; Yang L; Xiong W; Yang H; Xu K; Zhai E; Ding L; He Y; Song X
    Cancer Manag Res; 2019; 11():4917-4930. PubMed ID: 31213910
    [No Abstract]   [Full Text] [Related]  

  • 22. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
    Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
    Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation.
    Wu Z; Zhuo T; Li Z; Zhu Y; Wu J; Liang G; Dai L; Wang Y; Tan X; Chen M
    J Cancer; 2023; 14(12):2301-2314. PubMed ID: 37576392
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer.
    Zhang M; Zhou Z; Pan XK; Zhou YJ; Li HO; Qiu PS; Zhang MN; Peng RY; Wang HZ; Liu L; Liu J; Zhao Q
    Cancer Cell Int; 2020; 20():510. PubMed ID: 33088218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of LINC02560 in colorectal cancer correlates with tumor microenvironment immunity.
    Luo C; Liu F; Su W; Long P; Liang J; Hou W; Jiang H; Long X; Su G
    J Cancer; 2021; 12(24):7507-7517. PubMed ID: 35003370
    [No Abstract]   [Full Text] [Related]  

  • 26. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
    Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
    Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
    Zhang J; Wang Y; Ma J; Aimudula A
    Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
    Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
    BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic analysis of integrated bioinformatics to identify upregulated THBS2 expression in colorectal cancer cells inhibiting tumour immunity through the HIF1A/Lactic Acid/GPR132 pathway.
    Liu Y; Jiang C; Xu C; Gu L
    Cancer Cell Int; 2023 Oct; 23(1):253. PubMed ID: 37884956
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Zhao K; Yi Y; Ma Z; Zhang W
    Front Genet; 2021; 12():705512. PubMed ID: 35058963
    [No Abstract]   [Full Text] [Related]  

  • 32. USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance.
    Jin R; Luo Z; Jun-Li ; Tao Q; Wang P; Cai X; Jiang L; Zeng C; Chen Y
    Front Oncol; 2023; 13():1023292. PubMed ID: 36874086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
    Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
    Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
    Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
    Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
    Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
    J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ASB6 as an Independent Prognostic Biomarker for Colorectal Cancer Progression Involves Lymphatic Invasion and Immune Infiltration.
    Hu Q; Chen Y; Zhou Q; Deng S; Mu B; Tang J
    J Cancer; 2024; 15(9):2712-2730. PubMed ID: 38577591
    [No Abstract]   [Full Text] [Related]  

  • 37. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
    Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
    Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer.
    Huang W; Zhu L; Huang H; Li Y; Wang G; Zhang C
    BMC Cancer; 2023 Feb; 23(1):116. PubMed ID: 36732736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
    Kang K; Xie F; Mao J; Bai Y; Wang X
    Front Oncol; 2020; 10():573141. PubMed ID: 33072607
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden.
    Huang H; Cao W; Long Z; Kuang L; Li X; Feng Y; Wu Y; Zhao Y; Chen Y; Sun P; Peng P; Zhang J; Yuan L; Li T; Hu H; Li G; Yang L; Zhang X; Hu F; Sun X; Hu D
    Front Oncol; 2022; 12():1030335. PubMed ID: 36713578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.